Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the same

4,6-diamino-[1,7]naphthyridine-3-carbonitrile inhibitors of Tpl2 kinase and methods of making and using the same

US Patent 7432279 · Granted Oct 7, 2008

Estimated economic value: $183,534,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods using HDAC11 inhibitors2025
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists2025
Polysubstituted benzene compound and preparation method and use thereof2025
Isoquinoline compounds and uses thereof2025
CTPS1 inhibitors and uses thereof2025
Naphthyridine compounds and uses thereof2025
3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors2025
HPK1 antagonists and uses thereof2025
HPK1 antagonists and uses thereof2025
Bicyclic-fused heteroaryl or aryl compounds2025
Activating pyruvate kinase R2024
Peptide compound, application thereof and composition containing same2024